Literature DB >> 23121992

Comparative ability of comorbidity classification methods for administrative data to predict outcomes in patients with chronic obstructive pulmonary disease.

Peter C Austin1, Matthew B Stanbrook, Geoffrey M Anderson, Alice Newman, Andrea S Gershon.   

Abstract

PURPOSE: Administrative healthcare databases are used for health services research, comparative effectiveness studies, and measuring quality of care. Adjustment for comorbid illnesses is essential to such studies. Validation of methods to account for comorbid illnesses in administrative data for patients with chronic obstructive pulmonary disease (COPD) has been limited. Our objective was to compare the ability of the Charlson index, the Elixhauser method, and the Johns Hopkins' Aggregated Diagnosis Groups (ADGs) to predict outcomes in patients with COPD.
METHODS: Retrospective cohorts constructed using population-based administrative data of patients with incident (n = 216,735) and prevalent (n = 638,926) COPD in Ontario, Canada, were divided into derivation and validation datasets. The primary outcome was all-cause death within 1 year. Secondary outcomes included all-cause hospitalization, COPD-specific hospitalization, non-COPD hospitalization, and COPD exacerbations.
RESULTS: In both the incident and prevalent COPD cohorts, the three methods had comparable discrimination for predicting mortality (c-statistics in the validation sample of incident patients of 0.819 for the Charlson method versus 0.822 for the Elixhauser method versus 0.830 for the ADG method). All three methods had lower predictive accuracy for predicting nonfatal outcomes.
CONCLUSIONS: In a disease-specific cohort of COPD patients, all three methods allowed for accurate prediction of mortality, with the Johns Hopkins ADGs having marginally higher discrimination.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23121992      PMCID: PMC4617831          DOI: 10.1016/j.annepidem.2012.09.011

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  26 in total

1.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

2.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee.

Authors:  Lorcan P McGarvey; Matthias John; Julie A Anderson; Michael Zvarich; Robert A Wise
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

3.  The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.

Authors:  Nicholas R Anthonisen; Melissa A Skeans; Robert A Wise; Jure Manfreda; Richard E Kanner; John E Connett
Journal:  Ann Intern Med       Date:  2005-02-15       Impact factor: 25.391

4.  Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada.

Authors:  Peter C Austin; Carl van Walraven; Walter P Wodchis; Alice Newman; Geoffrey M Anderson
Journal:  Med Care       Date:  2011-10       Impact factor: 2.983

Review 5.  The natural history of chronic obstructive pulmonary disease.

Authors:  D M Mannino; G Watt; D Hole; C Gillis; C Hart; A McConnachie; G Davey Smith; M Upton; V Hawthorne; D D Sin; S F P Man; S Van Eeden; D W Mapel; J Vestbo
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

6.  Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study.

Authors:  Andrea S Gershon; Chengning Wang; Andrew S Wilton; Roxana Raut; Teresa To
Journal:  Arch Intern Med       Date:  2010-03-22

7.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

8.  International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.

Authors:  A Sonia Buist; Mary Ann McBurnie; William M Vollmer; Suzanne Gillespie; Peter Burney; David M Mannino; Ana M B Menezes; Sean D Sullivan; Todd A Lee; Kevin B Weiss; Robert L Jensen; Guy B Marks; Amund Gulsvik; Ewa Nizankowska-Mogilnicka
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

9.  Impact of comorbidities on stroke rehabilitation outcomes: does the method matter?

Authors:  Dan R Berlowitz; Helen Hoenig; Diane C Cowper; Pamela W Duncan; W Bruce Vogel
Journal:  Arch Phys Med Rehabil       Date:  2008-10       Impact factor: 3.966

10.  Development and application of a population-oriented measure of ambulatory care case-mix.

Authors:  J P Weiner; B H Starfield; D M Steinwachs; L M Mumford
Journal:  Med Care       Date:  1991-05       Impact factor: 2.983

View more
  31 in total

1.  The value of complementing administrative data with abstracted information on smoking and obesity: A study in kidney cancer.

Authors:  Madhur Nayan; Robert J Hamilton; Antonio Finelli; Peter C Austin; Girish S Kulkarni; David N Juurlink
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

2.  Does the frequency of routine follow-up after curative treatment for head-and-neck cancer affect survival?

Authors:  S F Hall; T Owen; R J Griffiths; K Brennan
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

3.  Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Liza Genao; Michael T Durheim; Xiaojuan Mi; Jamie L Todd; Heather E Whitson; Lesley H Curtis
Journal:  Ann Am Thorac Soc       Date:  2015-12

4.  Mental health outcomes after major trauma in Ontario: a population-based analysis.

Authors:  Christopher C D Evans; Yvonne DeWit; Dallas Seitz; Stephanie Mason; Avery Nathens; Stephen Hall
Journal:  CMAJ       Date:  2018-11-12       Impact factor: 8.262

5.  Exploration of ICD-9-CM coding of chronic disease within the Elixhauser Comorbidity Measure in patients with chronic heart failure.

Authors:  Jennifer Hornung Garvin; Andrew Redd; Dan Bolton; Pauline Graham; Dominic Roche; Peter Groeneveld; Molly Leecaster; Shuying Shen; Mark G Weiner
Journal:  Perspect Health Inf Manag       Date:  2013-10-01

Review 6.  A Systematic Review of Comorbidity Measurement Methods for Patients With Nontraumatic Brain Injury in Inpatient Rehabilitation Settings.

Authors:  Wayne Khuu; Vincy Chan; Angela Colantonio
Journal:  Am J Phys Med Rehabil       Date:  2017-11       Impact factor: 2.159

7.  COPD Hospitalization Risk Increased with Distinct Patterns of Multiple Systems Comorbidities Unveiled by Network Modeling.

Authors:  Young Ji Lee; Andrew D Boyd; Jianrong John Li; Vincent Gardeux; Colleen Kenost; Don Saner; Haiquan Li; Ivo Abraham; Jerry A Krishnan; Yves A Lussier
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

8.  The association between asthma and perinatal mental illness: a population-based cohort study.

Authors:  Amira M Aker; Simone N Vigod; Cindy-Lee Dennis; Tyler Kaster; Hilary K Brown
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

9.  Evaluation of risk adjustment performance of diagnosis-based and medication-based comorbidity indices in patients with chronic obstructive pulmonary disease.

Authors:  Huei Guo Ie; Chao-Hsiun Tang; Mei-Ling Sheu; Hung-Yi Liu; Ning Lu; Tuan-Ya Tsai; Bi-Li Chen; Kuo-Cherh Huang
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

10.  Case-Ascertainment Models to Identify Adults with Obstructive Sleep Apnea Using Health Administrative Data: Internal and External Validation.

Authors:  Tetyana Kendzerska; Carl van Walraven; Daniel I McIsaac; Marcus Povitz; Sunita Mulpuru; Isac Lima; Robert Talarico; Shawn D Aaron; William Reisman; Andrea S Gershon
Journal:  Clin Epidemiol       Date:  2021-06-17       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.